Market Tracker

04/29 5:16pm ET

Trovagene Inc (NASDAQ:TROV)

4.02
Delayed Data
As of Apr 29
 -0.14 / -3.37%
Today’s Change
2.85
Today|||52-Week Range
13.58
-25.56%
Year-to-Date

Today’s Trading

Previous close4.16
Today’s open4.20
Day’s range3.88 - 4.26
Volume681,361
Average volume (3 months)681,877
Market cap$123.9M
Dividend yield--
Data as of 4:00pm ET, 04/29/2016

Growth & Valuation

Earnings growth (last year)-37.50%
Earnings growth (this year)-19.52%
Earnings growth (next 5 years)--
Revenue growth (last year)+11.65%
P/E ratioNM
Price/Sales456.64
Price/Book2.54

Competitors

 Today’s
change
Today’s
% change
CALACalithera Bioscience...-0.16-2.91%
TRILTrillium Therapeutic...-0.58-4.92%
VCYTVeracyte Inc+0.01+0.17%
LNTHLantheus Holdings In...+0.01+0.49%
Data as of 4:00pm ET, 04/29/2016

Financials

Next reporting dateMay 3, 2016
EPS forecast (this quarter)-$0.30
Annual revenue (last year)$312.8K
Annual profit (last year)-$27.5M
Net profit margin-8,781.98%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer
William J. Welch
Chief Scientific Officer
Mark Erlander
Corporate headquarters
San Diego, California

Forecasts